In a dispute involving crucial questions around freedom of speech, private platform governance and trademark law, the ...

One of the most horrific cases of allegedly Grok-generated child sex images was shared in a proposed class action lawsuit ...

Google has filed a lawsuit against a cybercrime operation known as the “Outsider Enterprise,” accusing the group of running large-scale phishing and smishing campaigns that have targeted hundreds of ...

Google on Friday said it's pursuing legal action against a Chinese cybercrime network, accusing it of using its Gemini artificial intelligence (AI) agent to send phishing text messages targeting ...

This week we covered the release of the Google March 2026 core update that rolled out this morning and will take about two weeks to finish. We also covered Google March 2026 spam update that launched ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

The English-language edition of Wikipedia is blacklisting Archive.today after the controversial archive site was used to direct a distributed denial of service (DDoS) attack against a blog. In the ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...